Market Cap

BRAIN Biotechnology Research & Information Network AG Market Capitalization:

€84.3 Million

EUR as of Jan. 1, 2024

US$93.1 Million

business BRAIN Biotechnology Research & Information Network AG Company Profile

BRAIN Biotechnology Research & Information Network AG Main Stock Listings

Market Capitalization History of BRAIN Biotechnology Research & Information Network AG

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of BRAIN Biotechnology Research & Information Network AG market cap

Date Market Cap YoY Change
Jan. 1, 2024 €84.3 M -41.60%
Jan. 1, 2023 €144.4 M -32.20%
Jan. 1, 2022 €213.0 M 11.32%
Jan. 1, 2021 €191.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

BRAIN Biotechnology Research & Information Network AG Categories

Germany languages Healthcare languages Biotechnology
Germany Healthcare Germany Biotechnology

Stocks & Indices

BRAIN Biotechnology Research & Information Network AG has the following listings and related stock indices.


Stock: FSX: BNN

Stock: XETR: BNN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.